JP2025513785A5 - - Google Patents
Info
- Publication number
- JP2025513785A5 JP2025513785A5 JP2024559143A JP2024559143A JP2025513785A5 JP 2025513785 A5 JP2025513785 A5 JP 2025513785A5 JP 2024559143 A JP2024559143 A JP 2024559143A JP 2024559143 A JP2024559143 A JP 2024559143A JP 2025513785 A5 JP2025513785 A5 JP 2025513785A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- nucleic acid
- rnai
- identity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263328241P | 2022-04-06 | 2022-04-06 | |
| US63/328,241 | 2022-04-06 | ||
| US202363483075P | 2023-02-03 | 2023-02-03 | |
| US63/483,075 | 2023-02-03 | ||
| PCT/US2023/065388 WO2023196862A1 (en) | 2022-04-06 | 2023-04-05 | Targeted gene therapy for dm-1 myotonic dystrophy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025513785A JP2025513785A (ja) | 2025-04-30 |
| JP2025513785A5 true JP2025513785A5 (cg-RX-API-DMAC7.html) | 2026-04-13 |
Family
ID=86272086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024559143A Pending JP2025513785A (ja) | 2022-04-06 | 2023-04-05 | Dm-1筋強直性ジストロフィーの標的遺伝子療法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230365968A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4504936A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025513785A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240169111A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119234040A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023248463A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3247417A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2024013743A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL316078A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024012308A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202345914A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023196862A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024211480A2 (en) * | 2023-04-05 | 2024-10-10 | Genzyme Corporation | Targeted gene therapy for dm-1 myotonic dystrophy |
| WO2025137378A1 (en) * | 2023-12-20 | 2025-06-26 | Aavantibio, Inc. | Aav capsid engineering for cardiac and/or musculoskeletal gene therapy |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2264482A1 (en) | 1996-09-06 | 1998-03-12 | The Trustees Of The University Of Pennsylvania | An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase |
| US6566118B1 (en) | 1997-09-05 | 2003-05-20 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| US6995006B2 (en) | 1997-09-05 | 2006-02-07 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| US6596535B1 (en) | 1999-08-09 | 2003-07-22 | Targeted Genetics Corporation | Metabolically activated recombinant viral vectors and methods for the preparation and use |
| US7465583B2 (en) | 2000-06-01 | 2008-12-16 | The University Of North Carolina At Chapel Hill | Duplexed parvovirus vectors |
| US6723551B2 (en) | 2001-11-09 | 2004-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Production of adeno-associated virus in insect cells |
| CN103589692B (zh) | 2001-11-13 | 2018-07-24 | 宾夕法尼亚大学托管会 | 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法 |
| US8283151B2 (en) | 2005-04-29 | 2012-10-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes |
| US7588772B2 (en) | 2006-03-30 | 2009-09-15 | Board Of Trustees Of The Leland Stamford Junior University | AAV capsid library and AAV capsid proteins |
| WO2008134646A2 (en) | 2007-04-26 | 2008-11-06 | University Of Iowa Research Foundation | Rna interference suppression of neurodegenerative diseases and methods of use thereof |
| DK2164967T3 (en) | 2007-05-31 | 2015-10-19 | Univ Iowa Res Found | Reduction of off-target rna interferenstoksicitet |
| US9556433B2 (en) | 2012-07-17 | 2017-01-31 | Université De Genève | Nucleic acids for down-regulation of gene expression |
| WO2018178067A1 (en) * | 2017-03-27 | 2018-10-04 | Vrije Universiteit Brussel | Diaphragm-specific nucleic acid regulatory elements and methods and use thereof |
| EP3618839A4 (en) * | 2017-05-05 | 2021-06-09 | Voyager Therapeutics, Inc. | COMPOSITIONS AND METHODS OF TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) |
| WO2018226638A1 (en) * | 2017-06-05 | 2018-12-13 | The Brigham And Women's Hospital, Inc. | Vero cell lines stably expressing hsv icp0 protein |
| IL277270B2 (en) | 2018-03-16 | 2025-05-01 | Res Inst Nationwide Childrens Hospital | Increasing tissue-specific gene delivery through capsid modification |
| CA3097375A1 (en) | 2018-04-27 | 2019-10-31 | Universitat Heidelberg | Modified aav capsid polypeptides for treatment of muscular diseases |
| JP2021522836A (ja) * | 2018-05-15 | 2021-09-02 | ユニバーシティ オブ ワシントンUniversity of Washington | スプライスオパシーの軽減、及びrnaドミナンス障害の治療のための組成物及び方法 |
| TW202509215A (zh) * | 2018-08-03 | 2025-03-01 | 美商健臻公司 | 針對α-突觸核蛋白的變體RNAi |
| AU2019326551A1 (en) * | 2018-08-22 | 2021-03-18 | Research Institute At Nationwide Children's Hospital | Recombinant virus products and methods for inhibiting expression of dystrophia myotonica protein kinase and/or interfering with a trinucleotide repeat expansion in the 3' untranslated region of the DMPK gene |
| CN115279421A (zh) * | 2020-01-10 | 2022-11-01 | 坚固生物科技公司 | 用于联合疗法的病毒载体 |
-
2023
- 2023-04-05 KR KR1020247036731A patent/KR20240169111A/ko active Pending
- 2023-04-05 JP JP2024559143A patent/JP2025513785A/ja active Pending
- 2023-04-05 WO PCT/US2023/065388 patent/WO2023196862A1/en not_active Ceased
- 2023-04-05 US US18/296,283 patent/US20230365968A1/en active Pending
- 2023-04-05 CN CN202380041468.2A patent/CN119234040A/zh active Pending
- 2023-04-05 CA CA3247417A patent/CA3247417A1/en active Pending
- 2023-04-05 AU AU2023248463A patent/AU2023248463A1/en active Pending
- 2023-04-05 EP EP23720519.0A patent/EP4504936A1/en active Pending
- 2023-04-05 IL IL316078A patent/IL316078A/en unknown
- 2023-04-06 TW TW112112926A patent/TW202345914A/zh unknown
-
2024
- 2024-10-03 MX MX2024012308A patent/MX2024012308A/es unknown
- 2024-10-11 CO CONC2024/0013743A patent/CO2024013743A2/es unknown